Subscribe to the new podcast ‘Killing Lorenzen’ – Episode 3 just released

FDA recalls thyroid tablets

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

The FDA is recalling thyroid tablets because of potential problems with an ingredient.

The medication is Levothyroxine and Liothyronine in doses of 15 mg, 30 mg, 60 mg, 90 mg, and 120 mg.

The FDA says the Chinese maker of one of the ingredients in the drugs was found to have deficient manufacturing practices in a 2017 inspection.

Patients taking the recalled medicines should continue taking their medicine until they have a replacement product, the FDA said.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.